Asha Ramesh, CEO - Americas, dives into Sabinsa's exploration of specific turmeric-derived compounds to support diverse aspects of human health.
For more than three decades, Sabinsa has conducted extensive research on turmeric compounds, beginning with the introduction of its Curcumin C3 Complex® in the early 1990s. This extract has been the subject of more than 115 human clinical studies and numerous publications, contributing to its use as a reference material in academic and industry research. Building on this work, Sabinsa has also explored next-generation turmeric metabolites such as C3 Reduct® and other related compounds with potential roles in areas like metabolic, inflammatory, and cellular health.
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
